What you need to know
Jersey Shore University Medical Center is using a new method to treat cardiogenic shock by utilizing an advanced heart pump device, improving survival of patients.
Jersey Shore University Medical Center is only the third hospital in New Jersey following treatment protocols outlined by Henry Ford Health System’s National Cardiogenic Shock Initiative and accepted into the collaborative.
The treatment process includes standard techniques to open blocked coronary arteries, angioplasty and stent placement, combined with the use of state-of-the-art technology and reduction in medication given to patients.
Rapid placement of an Impella heart pump, labeled the world’s smallest by manufacturer ABIOMED, better prepares the patient’s heart to accept treatment and ensure blood is pumped to the rest of the body while allowing recovery. Jersey Shore University Medical Center’s Cardiogenic Shock Team then shares quality data on each patient with the National Cardiogenic Shock Initiative team to continue to develop best practices.
Jersey Shore University Medical Center performs more diagnostic and life-saving interventional cardiac procedures than any other hospital in the region and second most in New Jersey. As a leader in cardiovascular services, the medical center provides the only open and minimally invasive heart surgery program in Monmouth and Ocean counties.